Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Feng Ye, Saikat Dewanjee, Yuehua Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

Cancer treatment therapies: traditional to modern approaches to combat cancers
Rasanpreet Kaur, Alok Bhardwaj, Saurabh Gupta
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9663-9676
Closed Access | Times Cited: 101
A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer
Song Wu, Jibu Lu, Hongbo Zhu, et al.
Cancer Letters (2023) Vol. 581, pp. 216508-216508
Open Access | Times Cited: 98
Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 36
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer
Huanping Zhang, Ruiyuan Jiang, Jiayu Zhu, et al.
Breast Cancer (2024) Vol. 31, Iss. 4, pp. 539-551
Open Access | Times Cited: 27
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 16
Recent advancement in the detection of potential cancer biomarkers using the nanomaterial integrated electrochemical sensing technique: a detailed review
Hema Bhardwaj, ARCHANA ARCHANA, Ashab Noumani, et al.
Materials Advances (2024) Vol. 5, Iss. 2, pp. 475-503
Open Access | Times Cited: 15
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 15
Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022
Fanli Qu, Guanwen Wang, Ping Wen, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021
Tianye Li, Haoxiang Zhang, Mengyi Lian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth
Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1
Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases
Longyu Zhu, Miao Liu, Yuguang Shang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/m6A/ANGPTL4/integrin axis in triple-negative breast cancer
Siyue Zhang, Ning Zhang, Tong Wan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis
Zhigang Zhou, Jing Qin, Cailu Song, et al.
Journal of Cancer (2023) Vol. 14, Iss. 13, pp. 2574-2584
Open Access | Times Cited: 36
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 13
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer
Linyu Wu, Shanshan Huang, W. H. Tian, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 11
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 10
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges
Yingjie Jiang, Chunmei Yan, Minghao Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 135072-135072
Closed Access | Times Cited: 9
From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation
Siqi Wang, Fuchu He, Chunyan Tian, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 100-100
Open Access | Times Cited: 8
Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity
Avia D. Wilkerson, Corey K. Gentle, Camila Ortega, et al.
Healthcare (2024) Vol. 12, Iss. 4, pp. 462-462
Open Access | Times Cited: 8
A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis
Wenlong Chen, Yakun Kang, Wenyi Sheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Novel pH-responsive alginate-stabilized curcumin–selenium–ZIF-8 nanocomposites for synergistic breast cancer therapy
Emma Frouhar, Arghavan Adibifar, Maryam Salimi, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 4, pp. 444-455
Closed Access | Times Cited: 7
Paper-based screen-printed electrode to detect miRNA-652 associated to triple-negative breast cancer
Ada Raucci, Wanda Cimmino, Sara Pia Grosso, et al.
Electrochimica Acta (2024) Vol. 487, pp. 144205-144205
Open Access | Times Cited: 7
Epidermal growth factor receptor targeted photodynamic degrader to activate breast cancer immunity by intensifying immunogenic cell death and downregulating PD-L1
Keyan Zhang, Jun‐Mei Nie, Yeyang Wu, et al.
Chemical Engineering Journal (2025), pp. 160811-160811
Closed Access
Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity
Shulei Zhang, Zheng Bo, Yiqi Wei, et al.
Biomaterials Science (2024) Vol. 12, Iss. 10, pp. 2672-2688
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top